| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
Digg It - Conversation
It has been said that one of the greatest fears people hold is speaking in front of a group of people, yet we seem to have no shortage of public speakers. There is a kind of speaking that inspires grea According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ter fear. This is the fear of having a real conversation. Conversation is when two or more people talk openly and honestly, listen deeply to each other, and reach a common understanding. Agreement is ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ice, but irrelevant. The art of conversation is not about getting someone to agree with you. It is about seeking and finding a common understanding. The first goal in conversation is to understand the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. thinking of the other person. The second goal is to articulate one's own thinking in a way the other can understand. A true conversation is blameless, non judgmental, direct, and respectful. Conversati here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe n is a way of connecting. Most of us are afraid of a real conversation. If we really listen to someone else, it may upset our world view, our self image, or our view of life. We might find out we were d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro wrong. We might discover how they really feel about us. If we said what we really felt, the other person might be hurt, angry, disapproving, or judging. They might take action against us. We are afrai ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc of conflict. It poses a threat. We don't want to be rejected, hurt, or embarrassed. The thought of conflict provokes the flight or fight response. We either avoid or attack when we feel threatened. We easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi tend to do everything but engage in conversation. In our organizations and families we are starving for conversation. Blaming takes its place. It's easier. It's easier to tell myself how wrong you are nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically than it is to tell you I want to have a conversation. Many will say: "I tried that. I tried talking to that person." Trying to get someone to see it your way is not a conversation. It is certainly impo and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ tant to state your preferences. In conversation you are willing to suspend your judgments and conclusions while you listen to the other person. You are willing to allow new conclusions to arise as prod ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi cts of your mutual understanding. Conversation is responsive. In it we see the other person as a real person. We accept who they are. We see past perceived differences in gender, race, ethnicity, reli ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a gion, intelligence, sexual preference, economic status, age, profession, title, or background. The person with whom we are conversing is first, and foremost, a person. You are first, and foremost, a p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod rson. Moving beyond blaming makes it possible to have a conversation. Occasionally I meet someone I dislike. I purposely initiate a conversation. More often than not, I come away with an appreciation f cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin r the person. The dislike I felt was in me, not in them. It was my projection. How often do we give ourselves negative messages about others without actually talking to them? How often do our negative tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen thoughts become self fulfilling prophecies when we treat people as if they have already offended us? How often do we refuse to hear the facts because we already have an opinion? When you are experienc t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ng difficulty with others ask: "What is the conversation I am having and what impact is it having on this person? How am I allowing them to affect me?" Briefly step outside yourself and observe. Ask yo ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust rself if this situation is what you want. It is certainly okay to express your anger. For example, you could say, "When you did that, I was angry." Conversations are not always perfectly rational. Ju y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t remember you are talking to a real person. Conversations need not be devoid of emotion. Emotion adds meaning to conversation. Maintain an awareness of your emotion and the effect it is having on your . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de conversation. A lack of communication produces a void. People fill in the void with thoughts that assume blame. Insist on communicating with people. Refuse to blame them when they don't communicate wi elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip h you. Refuse to be disturbed by the opinions of others. Your ability to listen and to express your truth will be influential. Is there someone you are blaming right now? Consider having a conversation tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Fashion Jewelry Online Is Becoming Vital For Business Vehicle Leasing - A Case Study 5 Things Every Business Needs To Know About Packaging
|